Press coverage about St Jude Medical (NYSE:STJ) has been trending positive this week, according to AlphaOne Sentiment Analysis. AlphaOne, a service of Accern, identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.47 on AlphaOne’s scale. AlphaOne also assigned news headlines about the medical technology company an impact score of 96 out of 100, indicating that recent news coverage is extremely likely to have an effect on the stock’s share price in the near future.
Here are some of the media headlines that may have impacted Alpha One Sentiment’s rankings:
- Healthcare Earnings under Review – St. Jude Medical, Inc. (NYSE:STJ) – Stocks Gallery (press release) (stocksgallery.com)
- UPDATE 1-Abbott sales, profit propped up by St. Jude acquisition (businessinsider.com)
- St. Jude Medical fuels Abbott’s Street-beating Q1 results (massdevice.com)
- With St. Jude Medical in mix, Abbott reports revenue growth (startribune.com)
St Jude Medical (NYSE:STJ) remained flat at $80.82 during trading on Friday. St Jude Medical has a 12-month low of $48.83 and a 12-month high of $84.00. The stock’s 50 day moving average price is $79.78 and its 200 day moving average price is $79.88.
About St Jude Medical
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Receive News & Ratings for St Jude Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.